ithonpharma ltd
ithonpharma ltd Company Information
Company Number
10826472
Next Accounts
Mar 2025
Shareholders
paul aaron watson
alan cecil watson
View AllGroup Structure
View All
Industry
Dormant Company
Registered Address
rhos farm llanbadarn fynydd, llandrindod wells, LD1 6YN
Website
-ithonpharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ITHONPHARMA LTD at £0 based on a Turnover of £175.3k and 0x industry multiple (adjusted for size and gross margin).
ithonpharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ITHONPHARMA LTD at £0 based on an EBITDA of £0 and a 1.41x industry multiple (adjusted for size and gross margin).
ithonpharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ITHONPHARMA LTD at £40 based on Net Assets of £50 and 0.81x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ithonpharma Ltd Overview
Ithonpharma Ltd is a live company located in llandrindod wells, LD1 6YN with a Companies House number of 10826472. It operates in the dormant company sector, SIC Code 99999. Founded in June 2017, it's largest shareholder is paul aaron watson with a 20% stake. Ithonpharma Ltd is a young, micro sized company, Pomanda has estimated its turnover at £175.3k with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ithonpharma Ltd Health Check
Pomanda's financial health check has awarded Ithonpharma Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
4 Weak
Size
annual sales of £175.3k, make it smaller than the average company (£6.7m)
- Ithonpharma Ltd
£6.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 770%, show it is growing at a faster rate (4.2%)
- Ithonpharma Ltd
4.2% - Industry AVG
Production
with a gross margin of 17.4%, this company has a higher cost of product (33.2%)
- Ithonpharma Ltd
33.2% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Ithonpharma Ltd
- - Industry AVG
Employees
with 5 employees, this is below the industry average (57)
5 - Ithonpharma Ltd
57 - Industry AVG
Pay Structure
on an average salary of £39.1k, the company has an equivalent pay structure (£39.1k)
- Ithonpharma Ltd
£39.1k - Industry AVG
Efficiency
resulting in sales per employee of £35.1k, this is less efficient (£165.9k)
- Ithonpharma Ltd
£165.9k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (39 days)
- Ithonpharma Ltd
39 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Ithonpharma Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Ithonpharma Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Ithonpharma Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Ithonpharma Ltd
- - Industry AVG
ITHONPHARMA LTD financials
Ithonpharma Ltd's latest turnover from June 2023 is estimated at £175.3 thousand and the company has net assets of £50. According to their latest financial statements, Ithonpharma Ltd has 5 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 5 | 5 | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 50 | 50 | 50 | 50 | 50 | 50 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 50 | 50 | 50 | 50 | 50 | 50 |
| total assets | 50 | 50 | 50 | 50 | 50 | 50 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total current liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| net assets | 50 | 50 | 50 | 50 | 50 | 50 |
| total shareholders funds | 50 | 50 | 50 | 50 | 50 | 50 |
| Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 | Jun 2019 | Jun 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 50 |
| Creditors | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 |
ithonpharma ltd Credit Report and Business Information
Ithonpharma Ltd Competitor Analysis
Perform a competitor analysis for ithonpharma ltd by selecting its closest rivals, whether from the ACTIVITIES OF EXTRATERRITORIAL ORGANISATIONS AND BODIES sector, other micro companies, companies in LD1 area or any other competitors across 12 key performance metrics.
ithonpharma ltd Ownership
ITHONPHARMA LTD group structure
Ithonpharma Ltd has no subsidiary companies.
Ultimate parent company
ITHONPHARMA LTD
10826472
ithonpharma ltd directors
Ithonpharma Ltd currently has 5 directors. The longest serving directors include Mr Ryan Watson (Jun 2017) and Mr Alan Watson (Jun 2017).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Ryan Watson | United Kingdom | 34 years | Jun 2017 | - | Director |
| Mr Alan Watson | United Kingdom | 66 years | Jun 2017 | - | Director |
| Mrs Julie Watson | United Kingdom | 61 years | Jun 2017 | - | Director |
| Mr Paul Watson | United Kingdom | 35 years | Jun 2017 | - | Director |
| Ms Emma Watson | United Kingdom | 31 years | Jun 2017 | - | Director |
P&L
June 2023turnover
175.3k
+38%
operating profit
0
0%
gross margin
17.5%
-4.57%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
50
0%
total assets
50
0%
cash
0
0%
net assets
Total assets minus all liabilities
ithonpharma ltd company details
company number
10826472
Type
Private limited with Share Capital
industry
99999 - Dormant Company
incorporation date
June 2017
age
8
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
June 2023
previous names
N/A
accountant
BRADLEY RHODES LIMITED
auditor
-
address
rhos farm llanbadarn fynydd, llandrindod wells, LD1 6YN
Bank
-
Legal Advisor
-
ithonpharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ithonpharma ltd.
ithonpharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ITHONPHARMA LTD. This can take several minutes, an email will notify you when this has completed.
ithonpharma ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
